1. Companies

  2. Roche

Roche

Roche

Verified
Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
Launch date
Employees
10001+ people
Market cap
-
Net debt
-
Enterprise valuation
$207.4b (Public information from Jul 2024)
Company register number CHE-105.815.381
Basel Canton of Basel-Stadt (HQ)
http://roche.com
https://twitter.com/rochehttps://www.facebook.com/rochecareershttps://www.linkedin.com/company/rochehttps://apps.apple.com/app/id1102471373https://play.google.com/store/apps/details?id=eg.com.cat.roche
Deals in current and previous year:
Corporate Venture Fund: Roche Venture Fund

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
CHF2020202120222023202420252026
Revenues0000000000000000000000000000
% growth(5 %)8 %1 %(4 %)(1 %)6 %4 %
EBITDA0000000000000000000000000000
% EBITDA margin39 %36 %34 %31 %38 %38 %39 %
Profit0000000000000000000000000000
% profit margin25 %22 %20 %19 %22 %23 %24 %
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue22 %24 %25 %23 %---

Source: Dealroom estimates

    • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
*
N/A

$5.5b

Post IPO Debt
Total Funding000k

Related Content

Recent News about Roche

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit
By Country
United States 13Germany 3Austria 1Canada 1France 1Denmark 1Ireland 1United Kingdom 1Italy 1Switzerland 1Israel 1
By Industry
Health 23Telecom 1Enterprise Software 1
By Round
ACQUISITION 17SEED 2SERIES A 2EARLY VC 1POST IPO EQUITY 1LATE VC 1SERIES C 1

Investments by Roche

Edit
MySugr
MySugr
ACQUISITION by Roche Jun 2017
Spark Therapeutics
Spark Therapeutics
ACQUISITION by Roche Feb 2019
Ignyta
Ignyta
ACQUISITION by Roche Dec 2017
Tensha Therapeutics
Tensha Therapeutics
ACQUISITION by Roche Jan 2016
Arius Research
Arius Research
ACQUISITION by Roche Jul 2008
Flatiron Health
Flatiron Health
ACQUISITION by Roche Venture Fund Feb 2018
Carmot Therapeutics
Carmot Therapeutics
ACQUISITION by Roche Dec 2023
Affimed Therapeutics
Affimed Therapeutics
exited
Trophos
Trophos
ACQUISITION by Roche Jan 2015
Santaris Pharma
Santaris Pharma
ACQUISITION by Roche Aug 2014
View 58 more

Roche events

Edit
Bits & Pretzels Healthech
Bits & Pretzels Healthech
5–7 Jun 2024